GuruTrack

ARMISTICE CAPITAL, LLC

13F filer · CIK 1601086 · New York, NY

Summary
ARMISTICE CAPITAL, LLC reported $8.17B across 333 positions in its 13F for 2026 Q2, filed Aug 14, 2026. The largest holdings are MDGL (1.9%), SUPN (1.5%), CYTK (1.3%). Versus 2026 Q1, leaving options aside, it opened 169 new positions, added to 70, trimmed 64 and sold out of 97.
Reported value$8.17B
Positions333incl. options
Report period2026 Q2
FiledAug 14, 2026
New positions169
Added70
Trimmed64
Sold out97

Top 25 holdings

By reported value, options listed separately · change vs 2026 Q1

Weight 1.9%Value $154.64MPrice $509.44Shares 288K +8.85%Since Jun 30 -5.12%
Weight 1.5%Value $123.07MPrice $43.97Shares 2.65M +39.62%Since Jun 30 -5.46%
Weight 1.3%Value $102.34MPrice $65.64Shares 1.20M +57.13%Since Jun 30 -22.95%
Weight 1.2%Value $102.02MPrice $123.20Shares 900K +37.03%Since Jun 30 +8.68%
Weight 1.1%Value $90.31MPrice $138.35Shares 536K -25.99%Since Jun 30 -17.91%
Weight 1.1%Value $89.34MPrice $59.99Shares 1.57M -67.89%Since Jun 30 +5.60%
Weight 1.1%Value $89.06MPrice $33.30Shares 2.40M -11.63%Since Jun 30 -10.27%
Weight 1.1%Value $87.39MPrice $64.96Shares 1.07M -48.35%Since Jun 30 -20.36%
Weight 0.9%Value $76.06MPrice $374.94Shares 183K +23.65%Since Jun 30 -9.79%
Weight 0.9%Value $74.53MPrice $57.15Shares 1.26M +15.31%Since Jun 30 -3.33%
Weight 0.8%Value $68.57MPrice $16.21Shares 3.09M -2.77%Since Jun 30 -27.01%
Weight 0.8%Value $67.82MPrice $246.67Shares 285K +8.55%Since Jun 30 +3.50%
Weight 0.8%Value $66.89MPrice $33.46Shares 1.74M -51.30%Since Jun 30 -13.16%
Weight 0.8%Value $65.41MPrice $48.89Shares 1.67M +30.63%Since Jun 30 +24.97%
Weight 0.8%Value $61.41MPrice $679.61Shares 122K +33.87%Since Jun 30 +35.55%
Weight 0.7%Value $58.65MPrice $4.16Shares 13.93M -7.29%Since Jun 30 -1.19%
Weight 0.7%Value $56.95MPrice $39.29Shares 1.56M -3.69%Since Jun 30 +7.91%
Weight 0.7%Value $56.00MPrice $750.51Shares 90K +148.60%Since Jun 30 +20.36%
Weight 0.6%Value $50.54MPrice $59.24Shares 724K +25.26%Since Jun 30 -15.14%
Weight 0.6%Value $46.84MPrice $24.48Shares 1.74M +47.62%Since Jun 30 -9.27%
Weight 0.6%Value $45.39MPrice $40.74Shares 1.06M +254.67%Since Jun 30 -4.50%
Weight 0.6%Value $45.34MPrice $30.85Shares 1.43M +20.20%Since Jun 30 -2.83%
Weight 0.6%Value $45.21MPrice $340.92Shares 126K +6.73%Since Jun 30 -4.60%
Weight 0.5%Value $42.74MPrice $7.16Shares 4.28M +33.69%Since Jun 30 -28.33%
Weight 0.5%Value $42.05MPrice $337.19Shares 125K +16.66%Since Jun 30 +0.38%

Weight is the share of the reported 13F value, including options at notional value. “Since Jun 30” compares the latest close with the quarter-end price implied by the filing (value ÷ shares).

Largest buys in 2026 Q2

CYTKCYTKCYTOKINETICS INC≈ $37.21MAdd
SNYSNYSANOFI SA≈ $32.59MAdd
WATWATWATERS CORP≈ $28.13MNew

Largest sells in 2026 Q2

IMVTIMVTIMMUNOVANT INC≈ $45.43MTrim
AVNSAVNSAVANOS MED INC≈ $28.02MSold
MDLNMDLNMEDLINE INC≈ $25.14MSold

Options

Notional value, listed apart from stocks

Source: SEC Form 13F, values as reported by the filer. Filings lag up to 45 days after quarter end and cover only certain long positions. Research only, not investment advice.

Original filing All 13F filings on EDGAR